Dysregulation of kallikrein-related peptidases in renal cell carcinoma: Potential targets of miRNAs

Biological Chemistry

Volumn 391, Issue 4, 2010, Pages 411-423

  White, Nicole M ^a,b   Bui, Anna ^a   Mejia Guerrero, Salvador ^a,b   Chao, Julie ^c   Soosaipillai, Antoninus ^d   Youssef, Youssef ^a   Mankaruos, Marina ^a   Honey, R John ^e   Stewart, Robert ^e   Pace, Kenneth T ^e   Sugar, Linda ^f   Diamandis, Eleftherios P ^b,d   Doré, Jules ^g   Yousef, George M ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Cancer biomarker; Kallikrein; Kallikrein related peptidase; Kidney; Kidney cancer; MicroRNA; Renal cell carcinoma

Indexed keywords

KALLIKREIN; KALLIKREIN 1; KALLIKREIN 10; KALLIKREIN 11; KALLIKREIN 5; KALLIKREIN 6; MICRORNA; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; TUMOR MARKER; UNCLASSIFIED DRUG;

COMPUTER ANALYSIS; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME REGULATION; GENE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KLK 1 GENE; KLK 3 GENE; KLK 6 GENE; KLK 7 GENE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; COMPUTATIONAL BIOLOGY; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; KIDNEY NEOPLASMS; MICRORNAS; PHYLOGENY; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951484580     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2010.041     Document Type: Conference Paper

References (69)

1. Alamara, C., Karapanagiotou, E.M., Tourkantonis, I., Xyla, V., Maurer, C.C., Lykourinas, M., Pandha, H., and Syrigos, K.N. (2008). Renal oncocytoma: a case report and short review of the literature. Eur. J. Intern. Med. 19, e67-e69.
2. Ambs, S., Prueitt, R.L., Yi, M., Hudson, R.S., Howe, T.M., Petrocca, F., Wallace, T.A., Liu, C.G., Volinia, S., Calin, G.A., et al. (2008). Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 68, 6162-6170.
3. Bando, Y., Ito, S., Nagai, Y., Terayama, R., Kishibe, M., Jiang, Y.P., Mitrovic, B., Takahashi, T., and Yoshida, S. (2006). Implications of protease M/neurosin in myelination during experimental demyelination and remyelination. Neurosci. Lett. 405, 175-180.
4. Bentwich, I. (2005). Prediction and validation of microRNAs and their targets. FEBS Lett. 579, 5904-5910.
5. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
6. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
7. Camps, C., Buffa, F.M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., Harris, A.L., Gleadle, J.M., and Ragoussis, J. (2008). hsamiR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14, 1340-1348.
8. Capitanio, U., Cloutier, V., Zini, L., Isbarn, H., Jeldres, C., Shariat, S.F., Perrotte, P., Antebi, E., Patard, J.J., Montorsi, F., et al. (2009). A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int. 103, 1496-1500.
9. Chao, J. and Chao, L. (2005). Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp. Physiol. 90, 291-298.
10. Chow, T.F., Youssef, Y.M., Lianidou, E., Romaschin, A.D., Honey, R.J., Stewart, R., Pace, K.T., and Yousef, G.M. (2010). Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin. Biochem. 43, 150-158.
11. Clements, J. and Mukhtar, A. (1997). Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers. Immunopharmacology 36, 217-220.
12. Delahunt, B. (2009). Advances and controversies in grading and staging of renal cell carcinoma. Mod. Pathol. 22 (Suppl. 2), S24-S36.
13. Di, N.A. and Signoretti, S. (2009). Tissue biomarkers in renal cell carcinoma: issues and solutions. Cancer 115, 2290-2297.
14. Diamandis, E.P. and Yousef, G.M. (2002). Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 48, 1198-1205.
15. Emami, N. and Diamandis, E.P. (2007). Human tissue kallikreins: a road under construction. Clin. Chim. Acta 381, 78-84.
16. Esquela-Kerscher, A. and Slack, F.J. (2006). Oncomirs - micro-RNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
17. Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M.C., and Martelli, F. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J. Biol. Chem. 283, 15878-15883.
18. Furge, K.A., Tan, M.H., Dykema, K., Kort, E., Stadler, W., Yao, X., Zhou, M., and Teh, B.T. (2007). Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling. Oncogene 26, 1346-1350.
19. Gottardo, F., Liu, C.G., Ferracin, M., Calin, G.A., Fassan, M., Bassi, P., Sevignani, C., Byrne, D., Negrini, M., Pagano, F., et al. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25, 387-392.
20. Harris, A.L. (2002). Hypoxia: a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47.
21. Horii, K., Suzuki, Y., Kondo, Y., Akimoto, M., Nishimura, T., Yamabe, Y., Sakaue, M., Sano, T., Kitagawa, T., Himeno, S., et al. (2007). Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Mol. Cancer Res. 5, 383-391.
22. Huang, X., Ding, L., Bennewith, K.L., Tong, R.T., Welford, S.M., Ang, K.K., Story, M., Le, Q.T., and Giaccia, A.J. (2009). Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 35, 856-867.
23. John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C., and Marks, D.S. (2004). Human microRNA targets. PLoS Biol. 2, e363.
24. Jung, M., Ramankulov, A., Roigas, J., Johannsen, M., Ringsdorf, M., Kristiansen, G., and Jung, K. (2007). In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol. Biol. 8, 47.
25. Jung, M., Mollenkopf, H.J., Grimm, C., Wagner, I., Albrecht, M., Waller, T., Pilarsky, C., Johannsen, M., Stephan, C., Lehrach, H., et al. (2009). MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J. Cell. Mol. Med. 19, 3918-3928.
26. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., and Segal, E. (2007). The role of site accessibility in microRNA target recognition. Nat. Genet. 39, 1278-1284.
27. Kim, S.K., Nam, J.W., Rhee, J.K., Lee, W.J., and Zhang, B.T. (2006). miTarget: microRNA target gene prediction using a support vector machine. BMC Bioinformatics 7, 411.
28. Kim, Y.K., Yu, J., Han, T.S., Park, S.Y., Namkoong, B., Kim, D.H., Hur, K., Yoo, M.W., Lee, H.J., Yang, H.K., et al. (2009). Functional links between clustered microRNAs: suppression of cellcycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 37, 1672-1681.
29. Kiriakidou, M., Nelson, P.T., Kouranov, A., Fitziev, P., Bouyioukos, C., Mourelatos, Z., and Hatzigeorgiou, A. (2004). A combined computational- experimental approach predicts human micro-RNA targets. Genes Dev. 18, 1165-1178.
30. Klokk, T.I., Kilander, A., Xi, Z., Waehre, H., Risberg, B., Danielsen, H.E., and Saatcioglu, F. (2007). Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Res. 67, 5221-5230.
31. Kulshreshtha, R., Ferracin, M., Wojcik, S.E., Garzon, R., Alder, H., Agosto-Perez, F.J., Davuluri, R., Liu, C.G., Croce, C.M., Negrini, M., et al. (2007). A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867.
32. Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S., and Zucman-Rossi, J. (2008). MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963.
33. Lam, J.S., Klatte, T., Kim, H.L., Patard, J.J., Breda, A., Zisman, A., Pantuck, A.J., and Figlin, R.A. (2008). Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit. Rev. Oncol. Hematol. 65, 235-262.
34. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., and Burge, C.B. (2003). Prediction of mammalian microRNA targets. Cell 115, 787-798.
35. Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R.T., Chen, P.,Wang, Y., Yan, M., Qian, Z., et al. (2008). Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. USA 105, 15535-15540.
36. Li, Q., Wang, G., Shan, J.L., Yang, Z.X., Wang, H.Z., Feng, J., Zhen, J.J., Chen, C., Zhang, Z.M., Xu, W., et al. (2009a). MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J. Gastroenterol. Hepatol. 25, 164-171.
37. Li, Y., Tan, W., Neo, T.W., Aung, M.O., Wasser, S., Lim, S.G., and Tan, T.M. (2009b). Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 100, 1234-1242.
38. Madeddu, P., Emanueli, C., and El-Dahr, S. (2007). Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling. Nat. Clin. Pract. Nephrol. 3, 208-221.
39. Maher, E.R. and Kaelin, W.G., Jr. (1997). von Hippel-Lindau disease. Medicine (Baltimore) 76, 381-391.
40. Mees, S.T., Mardin, W.A., Sielker, S., Willscher, E., Senninger, N., Schleicher, C., Colombo-Benkmann, M., and Haier, J. (2009). Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann. Surg. Oncol. 16, 2339-2350.
41. Miranda, K.C., Huynh, T., Tay, Y., Ang, Y.S., Tam, W.L., Thomson, A.M., Lim, B., and Rigoutsos, I. (2006). A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217.
42. Naidoo, S. and Raidoo, D.M. (2009). Angiogenesis in cervical cancer is mediated by HeLa metabolites through endothelial cell tissue kallikrein. Oncol. Rep. 22, 285-293.
43. Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L.T., Hijiya, N., Uchida, T., Sato, F., et al. (2008). Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J. Pathol. 216, 418-427.
44. Naylor, S., Garcia, D., Parekh, D., Troyer, D., Grizzle, W., and Thompson, I. (2009). miRNA expression in kidney cancer. In: Proceedings of the 2009 Keystone Symposia on Molecular and Cellular Biology: microRNA and Cancer, Keystone, CO, USA.
45. Nikiforova, M.N., Tseng, G.C., Steward, D., Diorio, D., and Nikiforov, Y.E. (2008). MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. 93, 1600-1608.
46. Patard, J.J., Leray, E., Rioux-Leclercq, N., Cindolo, L., Ficarra, V., Zisman, A., de la Taille, A., Tostain, J., Artibani, W., Abbou, C.C., et al. (2005). Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J. Clin. Oncol. 23, 2763-2771.
47. Petraki, C.D., Gregorakis, A.K., Vaslamatzis, M.M., Papanastasiou, P.A., Yousef, G.M., Levesque, M.A., and Diamandis, E.P. (2006a). Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Tumour Biol. 27, 1-7.
48. Petraki, C.D., Papanastasiou, P.A., Karavana, V.N., and Diamandis, E.P. (2006b). Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol. Chem. 387, 653-663.
49. Pipinikas, C.P., Carter, N.D., Corbishley, C.M., and Fenske, C.D. (2008). HIF-1a mRNA gene expression levels in improved diagnosis of early stages of prostate cancer. Biomarkers 13, 680-691.
50. Prueitt, R.L., Yi, M., Hudson, R.S., Wallace, T.A., Howe, T.M., Yfantis, H.G., Lee, D.H., Stephens, R.M., Liu, C.G., Calin, G.A., et al. (2008). Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68, 1152-1164.
51. Rajewsky, N. and Socci, N.D. (2004). Computational identification of microRNA targets. Dev. Biol. 267, 529-535.
52. Rehmsmeier, M., Steffen, P., Hochsmann, M., and Giegerich, R. (2004). Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507-1517.
53. Riad, A., Zhuo, J.L., Schultheiss, H.P., and Tschope, C. (2007). The role of the renal kallikrein-kinin system in diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 16, 22-26.
54. Rusinov, V., Baev, V., Minkov, I.N., and Tabler, M. (2005). MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res. 33, W696-W700.
55. Shaw, J.L. and Diamandis, E.P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432.
56. Shimono, Y., Zabala, M., Cho, R.W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S.P., Chiao, E., et al. (2009). Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603.
57. Shinoda, Y., Kozaki, K., Imoto, I., Obara, W., Tsuda, H., Mizutani, Y., Shuin, T., Fujioka, T., Miki, T., and Inazawa, J. (2007). Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci. 98, 1078-1086.
58. Shivdasani, R.A. (2006). MicroRNAs: regulators of gene expression and cell differentiation. Blood 108, 3646-3653.
59. Thongboonkerd, V., Gozal, E., Sachleben, L.R., Jr., Arthur, J.M., Pierce, W.M., Cai, J., Chao, J., Bader, M., Pesquero, J.B., Gozal, D., and Klein, J.B. (2002). Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J. Biol. Chem. 277, 34708-34716.
60. Tuschl, T., Zamore, P.D., Lehmann, R., Bartel, D.P., and Sharp, P.A. (1999). Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13, 3191-3197.
61. Wang, X. and El Naqa, I.M. (2008). Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24, 325-332.
62. Wang, P., Zou, F., Zhang, X., Li, H., Dulak, A., Tomko, R.J., Jr., Lazo, J.S., Wang, Z., Zhang, L., and Yu, J. (2009). microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 69, 8157-8165.
63. Yang, H., Kong, W., He, L., Zhao, J.J., O'Donnell, J.D., Wang, J., Wenham, R.M., Coppola, D., Kruk, P.A., Nicosia, S.V., et al. (2008). MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433.
64. Yousef, G.M. and Diamandis, E.P. (2002). Expanded human tissue kallikrein family - a novel panel of cancer biomarkers. Tumour Biol. 23, 185-192.
65. Yousef, G.M. and Diamandis, E.P. (2003). An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers. Clin. Biochem. 36, 443-452.
66. Yousef, G.M., Obiezu, C.V., Luo, L.Y., Magklara, A., Borgono, C.A., Kishi, T., Memari, N., Michael, P., Sidiropoulos, M., Kurlender, L., et al. (2005). Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem. 39, 11-79.
67. Yousef, M., Jung, S., Kossenkov, A.V., Showe, L.C., and Showe, M.K. (2007). Naive Bayes for microRNA target predictions: machine learning for microRNA targets. Bioinformatics 23, 2987-2992.
68. Yu, J., Wang, F., Yang, G.H., Wang, F.L., Ma, Y.N., Du, Z.W., and Zhang, J.W. (2006). Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem. Biophys. Res. Commun. 349, 59-68.
69. Zhang, B., Pan, X., Cobb, G.P., and Anderson, T.A. (2007). microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1-12.